John D. Gordan
- Molecular Biology top 1%
- Cancer Research top 0.5%
- Oncology top 2%
- Immunology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- M. Celeste SimonJ. Alan DiehlCraig B. ThompsonCheng‐Jun HuJianping JinSara B. CullinanJ. Wade HarperJessica A. Bertout
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (16 papers)Cancer, Hypoxia, and Metabolism (12 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Experimental Medicine
- Partner nations
- United StatesGermanyChina
In The Last Decade
John D. Gordan
68 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Biology 4.0k
- Cancer Research 2.6k
- Oncology 1.1k
- Immunology 757
- Pulmonary and Respiratory Medicine 694
Countries citing papers authored by John D. Gordan
This map shows the geographic impact of John D. Gordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Gordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Gordan more than expected).
Fields of papers citing papers by John D. Gordan
This network shows the impact of papers produced by John D. Gordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Gordan. The network helps show where John D. Gordan may publish in the future.
Co-authorship network of co-authors of John D. Gordan
This figure shows the co-authorship network connecting the top 25 collaborators of John D. Gordan. A scholar is included among the top collaborators of John D. Gordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Gordan. John D. Gordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 22 | |
| 7 | 6 | |
| 8 | 47 | |
| 9 | 25 | |
| 10 | 67 | |
| 11 | 3 | |
| 12 | 24 | |
| 13 | 31 | |
| 14 | 55 | |
| 15 | 43 | |
| 16 | 148 | |
| 17 | 92 | |
| 18 | HIF-2α Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activitybreakdown → | 619 |
| 19 | 337 | |
| 20 | 81 |
About John D. Gordan
John D. Gordan is a scholar working on Hepatology, Cancer Research and Oncology, having authored 72 papers that have together received 5.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). The work is most often cited by research in Cancer Research (2.6k citations), Molecular Biology (4.0k citations) and Oncology (1.1k citations). John D. Gordan has collaborated with scholars based in United States, Germany and China. Frequent co-authors include M. Celeste Simon, J. Alan Diehl, Craig B. Thompson, Cheng‐Jun Hu, Jianping Jin, Sara B. Cullinan, J. Wade Harper, Jessica A. Bertout, Brian Keith and Kelly L. Covello. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.